雅培(ABT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABT 雅培

休市中 05-03 16:00:00 EDT

105.90

-0.02

-0.02%

盘后105.46

-0.44-0.42%

19:50 EDT

最高106.64	最低105.48	成交量361.05万
今开106.11	昨收105.92	日振幅1.10%
总市值1,838亿	流通市值1,826亿	总股本17.35亿
成交额3.82亿	换手率0.21%	流通股本17.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABT","market":"US","secType":"STK","nameCN":"雅培","latestPrice":105.9,"timestamp":1714766400000,"preClose":105.92,"halted":0,"volume":3610492,"hourTrading":{"tag":"盘后","latestPrice":105.46,"preClose":105.9,"latestTime":"19:50 EDT","volume":337649,"amount":35756928.8406,"timestamp":1714780226324},"delay":0,"floatShares":1723863599,"shares":1735184289,"eps":3.210031,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"05-03 16:00:00 EDT","open":106.11,"high":106.64,"low":105.475,"amount":382461150.59616,"amplitude":0.010999,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.210031,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":-1293822000000,"adjPreClose":105.92,"adrRate":0,"dividendRate":0.020019,"preHourTrading":{"tag":"盘前","latestPrice":106.07,"preClose":105.92,"latestTime":"09:18 EDT","volume":407,"amount":43184.969432,"timestamp":1714742310502},"postHourTrading":{"tag":"盘后","latestPrice":105.46,"preClose":105.9,"latestTime":"19:50 EDT","volume":337649,"amount":35756928.8406,"timestamp":1714780226324},"volumeRatio":0.9134854136781004},"requestUrl":"/m/hq/s/ABT/","defaultTab":"news","newsList":[{"id":"2432670477","title":"医疗器械需求强劲，百特上调年度盈利预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432670477","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432670477?lang=zh_cn&edition=full","pubTime":"2024-05-02 20:28","pubTimestamp":1714652917,"startTime":"0","endTime":"0","summary":"    路透5月2日 - 医疗设备制造商百特国际  周四上调了年度利润预期，季度业绩超过预期，主要得益于输液泵和透析产品的强劲需求。自去年11月以来，投资者对医疗设备制造商业绩的预期一直在提高，原因是在COVID-19大流行期间被推迟的手术需求增加，尤其是老年人。百特公司表示，去年1月提出的肾脏护理部门分拆预计将在2024年下半年进行。第一季度营收同比增长 2%，达到 35.9 亿美元，高于预期的 35.5 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432467967","title":"手术设备需求强劲，百通迪金森上调利润预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2432467967","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432467967?lang=zh_cn&edition=full","pubTime":"2024-05-02 19:25","pubTimestamp":1714649144,"startTime":"0","endTime":"0","summary":"    路透5月2日 - 拜登迪金森  周四上调了全年利润预期，第二季度利润超过预期，因为该集团依靠的是对其手术设备和注射器的强劲需求。提供手术和重症监护设备的介入部门本季度的销售额为 12.9 亿美元，高于预期的 11.9 亿美元。集团总收入同比增长 4.6%，达到 50.5 亿美元，略高于预期的 50.4 亿美元。截至3月31日的第二季度，Becton公司调整后每股利润为3.17美元，高于分析师预计的每股2.97美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432848045","title":"雅培下跌1.23%，报105.955美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432848045","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432848045?lang=zh_cn&edition=full","pubTime":"2024-05-01 03:44","pubTimestamp":1714506296,"startTime":"0","endTime":"0","summary":"5月1日，雅培(ABT)盘中下跌1.23%，截至03:44，报105.955美元/股，成交2.85亿美元。财务数据显示，截至2024年03月31日，雅培收入总额99.64亿美元，同比增长2.23%；归母净利润12.25亿美元，同比减少7.06%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/05/01034440501464.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429253809","title":"巴克莱：维持Abbott Laboratories(ABT.US)评级，由增持调整至增持评级, 目标价由141.00美元调整至140.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429253809","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429253809?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:46","pubTimestamp":1713789977,"startTime":"0","endTime":"0","summary":"巴克莱：维持Abbott Laboratories(ABT.US)评级，由增持调整至增持评级, 目标价由141.00美元调整至140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222046208b462d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222046208b462d6f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428255323","title":"美国研究综述-建筑商第一资源公司、礼来公司、北方信托公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2428255323","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428255323?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:33","pubTimestamp":1713425634,"startTime":"0","endTime":"0","summary":"    路透社4月18日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括Builders Firstsource、礼来和北方信托。要闻             * Builders Firstsource Inc   ：杰富瑞将目标价从226美元上调至237美元             * 礼来  ：杰富瑞将目标价从885美元上调至895美元             * 北方信托公司  ：杰富瑞将目标价从 101 美元上调至 103 美元 以下是路透社周四报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428558755","title":"雅培：第一季度净利润减少7.06%至12.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428558755","media":"观点新媒体","top":-1,"share":"https://www.laohu8.com/m/news/2428558755?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:02","pubTimestamp":1713423748,"startTime":"0","endTime":"0","summary":"观点网讯：4月18日，雅培公布其2024财年第一季度财务报告。报告显示，该公司在报告期内实现总收入99.64亿美元，相较去年同期的97.47亿美元增长2.23%。净利润却出现下滑，本季度为12.25亿美元，去年同期为13.18亿美元，同比减少7.06%。基本每股收益也从去年同期的0.7579美元降至0.706美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418150358878e6fbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418150358878e6fbe&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428539423","title":"雅培2024财年第一财季实现收入99.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428539423","media":"北京商报","top":-1,"share":"https://www.laohu8.com/m/news/2428539423?lang=zh_cn&edition=full","pubTime":"2024-04-18 13:45","pubTimestamp":1713419100,"startTime":"0","endTime":"0","summary":"北京商报讯 4月18日，雅培发布2024财年第一财季财报显示，期内实现收入99.64亿美元，去年同期收入为97.47亿美元，同比增长2.23%。2024财年第一财季净利润12.25亿美元，去年同期净利润为13.18亿美元，同比减少7.06%。基本每股收益为0.706美元，去年同期为0.7579美元。按业务划分，雅培全球营养品业务销售额同比增长5.1%，有机增长7.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-04-18/doc-inasfrnu8437293.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-04-18/doc-inasfrnu8437293.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428199305","title":"隔夜美股全复盘(4.18)| 三大股指集体收跌，纳指跌超1%，英伟达跌近4%；美光盘后一度涨逾2%，下周有望获得超过60亿美元的芯片法案拨款","url":"https://stock-news.laohu8.com/highlight/detail?id=2428199305","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2428199305?lang=zh_cn&edition=full","pubTime":"2024-04-18 07:34","pubTimestamp":1713396844,"startTime":"0","endTime":"0","summary":"三大股指集体收跌，纳指跌超1%，英伟达跌近4%；美光盘后一度涨逾2%，下周有望获得超过60亿美元的芯片法案拨款","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/140.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/140.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/720604","is_publish_highlight":false,"gpt_icon":0},{"id":"2428832922","title":"雅培2023财年实现净利润57.01亿美元，同比减少17.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428832922","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428832922?lang=zh_cn&edition=full","pubTime":"2024-04-18 01:03","pubTimestamp":1713373435,"startTime":"0","endTime":"0","summary":"12月31日，雅培公布财报，公告显示公司2023财年净利润为57.01亿美元，同比减少17.44%；其中营业收入为401.09亿美元，同比减少8.12%，每股基本收益为3.28美元。从资产负债表来看，雅培总负债343.87亿美元，其中短期债务13.25亿美元，资产负债比为2.13，流动比率为1.64。机构评级：截至2023年12月31日，当前有21家机构对雅培目标价做出预测，其中目标均价为126.73美元，其中最低目标价为107.00美元，最高目标价为141.00美元。雅培约 60% 的销售额来自美国以外地区。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418010356878b1259&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418010356878b1259&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428995345","title":"雅培实验室公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2428995345","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428995345?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:32","pubTimestamp":1713360749,"startTime":"0","endTime":"0","summary":"   * 雅培实验室  公布的截至 3 月份的季度调整后每股收益为 98 美分，低于去年同期的每股收益 1.03 美元。21位分析师对该季度的平均预期是每股收益95美分。华尔街预期为每股收益 94 美分至 99 美分。* 雅培实验室公布的本季度每股收益为 70 美分。* 公司报告的季度净收入为 12.3 亿美元。* 雅培实验室本季度股价下跌了 3.9%，今年迄今为止下跌了 0.8%。华尔街对雅培实验室 12 个月目标价的中位数为 129.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428176593","title":"雅培Q1营收超预期，上调全年调整后EPS指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2428176593","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428176593?lang=zh_cn&edition=full","pubTime":"2024-04-17 20:29","pubTimestamp":1713356940,"startTime":"0","endTime":"0","summary":"智通财经获悉，雅培公布了第一季度财务业绩。同时，雅培上调了年度利润预期区间的下限。调整后每股收益为0.98美元，但高于预期的0.95美元。雅培预计今年调整后EPS将在4.55美元至4.70美元之间，此前的指引是4.50美元至4.70美元，与预期一致。最近几个季度，由于对关节置换和其他在新冠肺炎疫情期间被推迟的手术的需求复苏，雅培医疗器械的销售有所加强。雅培连续血糖监测仪本季度的销售额为15亿美元，而分析师预期为14.5亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/6a8642475395bb363eacb86148917e7b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6a8642475395bb363eacb86148917e7b"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104139.html","is_publish_highlight":true,"gpt_icon":1},{"id":"2428510310","title":"Abbott Laboratories(ABT.US)：2024年Q1财报实现营收99.64亿美元，","url":"https://stock-news.laohu8.com/highlight/detail?id=2428510310","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428510310?lang=zh_cn&edition=full","pubTime":"2024-04-17 20:20","pubTimestamp":1713356449,"startTime":"0","endTime":"0","summary":"Abbott Laboratories(ABT.US)：2024年Q1财报实现营收99.64亿美元，前值为97.47亿美元，预期值为98.8亿美元；每股收益为0.98美元，前值为1.03美元，预期值为0.95美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041720371187899837&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041720371187899837&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428517319","title":"雅培医疗器械销售强劲，季度利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2428517319","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428517319?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:30","pubTimestamp":1713353405,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月17日 - 雅培实验室  周三公布的季度利润超出华尔街预期，并上调了预期下限，原因是强劲的医疗程序需求促进了其设备（包括血糖监测产品）的销售。LSEG 数据显示，经调整后，该公司的年度利润为每股98 美分，而分析师预计为每股95 美分 。该公司目前预计全年每股利润为 4.55 美元至 4.70 美元 ，将下限 从每股 4.50 美元 上调。分析师预计每股利润为 4.60 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427907033","title":"雅培  预计每股收益95美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2427907033","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427907033?lang=zh_cn&edition=full","pubTime":"2024-04-15 20:38","pubTimestamp":1713184689,"startTime":"0","endTime":"0","summary":"* 根据LSEG的数据，18位分析师的平均预期显示，这家总部位于美国伊利诺伊州雅培园区的公司的营收将从去年同期的97.5亿美元增长1.4%，达到98.8亿美元。)   * LSEG 分析师对雅培实验室的平均预期为每股收益 95 美分。该公司在 2024 年 1 月 24 日发布的截至 3 月 31 日的每股收益指导介于 0.93 美元和 0.97 美元之间。* 华尔街对雅培制药的 12 个月目标价中位数为 128.00 美元，高于其上一次收盘价 109.11 美元。4月15日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426731161","title":"雅培下跌1.23%，报109.53美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426731161","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426731161?lang=zh_cn&edition=full","pubTime":"2024-04-12 23:23","pubTimestamp":1712935439,"startTime":"0","endTime":"0","summary":"4月12日，雅培(ABT)盘中下跌1.23%，截至23:23，报109.53美元/股，成交1.1亿美元。财务数据显示，截至2023年12月31日，雅培收入总额401.09亿美元，同比减少8.12%；归母净利润57.23亿美元，同比减少17.45%。大事提醒：4月17日，雅培将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/12232340224069.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426110788","title":"雅培上涨1.22%，报111.87美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426110788","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426110788?lang=zh_cn&edition=full","pubTime":"2024-04-10 00:43","pubTimestamp":1712681032,"startTime":"0","endTime":"0","summary":"4月10日，雅培(ABT)盘中上涨1.22%，截至00:43，报111.87美元/股，成交1.36亿美元。财务数据显示，截至2023年12月31日，雅培收入总额401.09亿美元，同比减少8.12%；归母净利润57.23亿美元，同比减少17.45%。大事提醒：4月17日，雅培将于(美东)盘前披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/10004340171295.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425344517","title":"雅培下跌1.21%，报109.93美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425344517","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425344517?lang=zh_cn&edition=full","pubTime":"2024-04-05 02:57","pubTimestamp":1712257066,"startTime":"0","endTime":"0","summary":"4月5日，雅培(ABT)盘中下跌1.21%，截至02:57，报109.93美元/股，成交2.43亿美元。财务数据显示，截至2023年12月31日，雅培收入总额401.09亿美元，同比减少8.12%；归母净利润57.23亿美元，同比减少17.45%。大事提醒：4月3日，雅培获花旗上调目标价至128美元，最新评级Buy。4月17日，雅培将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/05025740127798.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424010377","title":"美国 FDA 批准雅培的心脏瓣膜修复装置","url":"https://stock-news.laohu8.com/highlight/detail?id=2424010377","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424010377?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:07","pubTimestamp":1712063241,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透社4月2日 - 雅培实验室  周二称，美国食品和药物管理局已批准其心脏瓣膜修复装置，该装置专为在手术中面临并发症或死亡风险的患者设计。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424741324","title":"雅培下跌1.21%，报112.29美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424741324","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424741324?lang=zh_cn&edition=full","pubTime":"2024-04-01 23:04","pubTimestamp":1711983894,"startTime":"0","endTime":"0","summary":"4月1日，雅培(ABT)盘中下跌1.21%，截至23:04，报112.29美元/股，成交7188.28万美元。财务数据显示，截至2023年12月31日，雅培收入总额401.09亿美元，同比减少8.12%；归母净利润57.23亿美元，同比减少17.45%。大事提醒：4月17日，雅培将于(美东)盘前披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/01230440084230.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422580341","title":"雅培：多方聚力 提升消化健康关注度","url":"https://stock-news.laohu8.com/highlight/detail?id=2422580341","media":"经济参考网","top":-1,"share":"https://www.laohu8.com/m/news/2422580341?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:08","pubTimestamp":1711613321,"startTime":"0","endTime":"0","summary":"然而，随着逐渐加快的生活节奏和变化的饮食结构，消化系统疾病的发病率逐年上升。由于消化系统疾病类别复杂，且大多数为慢性病，很容易被忽视。其中，渗透性药物中的乳果糖便是慢性便秘的一线长期用药。结直肠癌是消化道中较为常见的肿瘤，近年来发病率和死亡率也在持续上升。据悉，作为消化系统领域的领导者，雅培将持续与各界合作，不断探索创新的治疗解决方案，提高大众对于消化系统健康问题的重视程度。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281615478b6cea80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403281615478b6cea80&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbott.com;www.abbottinvestor.com","stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":-0.0483},{"period":"3month","weight":-0.0554},{"period":"6month","weight":0.105},{"period":"1year","weight":-0.0447},{"period":"ytd","weight":-0.0379}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"雅培公司是一家伊利诺伊州的公司，于1900年注册成立。雅培公司的主要业务为研究、开发、制造及销售保健品，有四个可报告的部门：既有药品、诊断产品、营养产品和医疗器械。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.007113},{"month":2,"riseRate":0.545455,"avgChangeRate":0.008719},{"month":3,"riseRate":0.545455,"avgChangeRate":0.010108},{"month":4,"riseRate":0.622222,"avgChangeRate":0.021859},{"month":5,"riseRate":0.6,"avgChangeRate":0.011447},{"month":6,"riseRate":0.5,"avgChangeRate":-0.014172},{"month":7,"riseRate":0.636364,"avgChangeRate":0.016866},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.001787},{"month":9,"riseRate":0.522727,"avgChangeRate":0.004216},{"month":10,"riseRate":0.636364,"avgChangeRate":0.016499},{"month":11,"riseRate":0.704545,"avgChangeRate":0.017481},{"month":12,"riseRate":0.727273,"avgChangeRate":0.016723}],"exchange":"NYSE","name":"雅培","nameEN":"Abbott Laboratories"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"雅培(ABT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供雅培(ABT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"雅培,ABT,雅培股票,雅培股票老虎,雅培股票老虎国际,雅培行情,雅培股票行情,雅培股价,雅培股市,雅培股票价格,雅培股票交易,雅培股票购买,雅培股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"雅培(ABT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供雅培(ABT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}